Загрузка...
Atypical Femoral Fracture: 2015 Position Statement of the Korean Society for Bone and Mineral Research
Bisphosphonate (BP) is a useful anti-resorptive agent which decreases the risk of osteoporotic fracture by about 50%. However, recent evidences have shown its strong correlation with the occurrence of atypical femoral fracture (AFF). The longer the patient takes BP, the higher the risk of AFF. Also,...
Сохранить в:
| Опубликовано в: : | J Bone Metab |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
The Korean Society for Bone and Mineral Research
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4572036/ https://ncbi.nlm.nih.gov/pubmed/26389082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11005/jbm.2015.22.3.87 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|